Clinical Trial Update: Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM) [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing Dual Release Hydrocortisone to conventional glucocorticoid replacement in hypocortisolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Insufficiency

Drugs mentioned

• Dual Release Hydrocortisone
• conventional glucocorticoid replacement therapy (glucocorticoid)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Primary Adrenal Insufficiency, Secondary Adrenal Insufficiency | Phase 4 | Status: COMPLETED